Type 1 Diabetes News and Research RSS Feed - Type 1 Diabetes News and Research

Type 1 diabetes, formerly called juvenile diabetes or insulin-dependent diabetes, is usually first diagnosed in children, teenagers, or young adults. In this form of diabetes, the beta cells of the pancreas no longer make insulin because the body’s immune system has attacked and destroyed them. Treatment for type 1 diabetes includes taking insulin shots or using an insulin pump, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.
The scent dogs smell on diabetics’ breath could offer key to new tests

The scent dogs smell on diabetics’ breath could offer key to new tests

An increase in the level of the chemical isoprene may be the warning sign some dogs can detect in the breath of patients with type 1 diabetes who are reaching risky low levels of blood sugar, according to research by the University of Cambridge. [More]
Scientists discover link between two genes involved in PD and autoimmune diseases

Scientists discover link between two genes involved in PD and autoimmune diseases

A study publish in the journal CELL indicates that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease. [More]
Researchers seek to develop inexpensive electronic nose for breath analysis

Researchers seek to develop inexpensive electronic nose for breath analysis

Researchers at the Texas Analog Center of Excellence (TxACE) at UT Dallas are working to develop an affordable electronic nose that can be used in breath analysis for a wide range of health diagnosis. [More]
Mice study highlights vital role of liver in balancing fats and sugars

Mice study highlights vital role of liver in balancing fats and sugars

Sugar in the form of blood glucose provides essential energy for cells. When its usual dietary source — carbohydrates — is scarce, the liver can produce it with the aid of fat. [More]
MPC outperforms PID in automated insulin delivery for patients with type 1 diabetes mellitus

MPC outperforms PID in automated insulin delivery for patients with type 1 diabetes mellitus

The so-called artificial pancreas — an automated insulin delivery system for people with type 1 diabetes mellitus — uses an advanced control algorithm to regulate how much insulin a pump should deliver and when. Regulating glucose is challenging because levels respond to a wide-array of variables, including food, physical activity, sleep, stress, hormones, metabolism and more. [More]
ACCORDION study shows lowering blood glucose can reduce progression of diabetic retinopathy

ACCORDION study shows lowering blood glucose can reduce progression of diabetic retinopathy

People with type 2 diabetes who intensively controlled their blood sugar level during the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy. [More]
Type 1 diabetes occurs more frequently in patients with JIA

Type 1 diabetes occurs more frequently in patients with JIA

The results of a study involving more than 9,000 patients, presented today at the European League Against Rheumatism Annual Congress showed that Type 1 diabetes occurs significantly more frequently in patients with Juvenile Inflammatory Arthritis (JIA) than in the general population. [More]
Automated OCL insulin feedback controller improves glucose control in diabetic children, adolescents

Automated OCL insulin feedback controller improves glucose control in diabetic children, adolescents

Using an automated insulin feedback controller as part of an overnight closed-loop (OCL) control system improved glucose control (increased time within target glucose range) and reduced episodes of nocturnal hypoglycemia in children and adolescents. [More]
Diabetes societies endorse 'metabolic surgery'

Diabetes societies endorse 'metabolic surgery'

An "unprecedented" number of societies have endorsed guidelines recommending metabolic surgery for patients with diabetes - and not just for patients with severe obesity. [More]
New collaborative research center to investigate promising aspects of mucosal immunology

New collaborative research center to investigate promising aspects of mucosal immunology

Immunology - and the idea that many diseases can best be addressed by boosting the body's own immune response - is one of the hottest areas in medical research and clinical treatment. [More]
CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

CGT, University of Aberdeen announce creation of new company to develop novel technology for diabetes treatment

The Cell and Gene Therapy Catapult and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production. [More]
Insulin pump therapy can benefit all type 1 diabetes patients

Insulin pump therapy can benefit all type 1 diabetes patients

Insulin pump therapy contributes to better blood glucose control in type 1 diabetes and, as pump technology continues to improve and become part of sensor-controlled feedback and artificial pancreas systems, essentially all patients would benefit from their capabilities according to a Commentary published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. [More]
Could worm infection counter IBD? An interview with Dr Loke and Dr Cadwell

Could worm infection counter IBD? An interview with Dr Loke and Dr Cadwell

The hygiene hypothesis refers to the idea that decreased exposure to certain infectious agents (because of better hygiene) is the reason why we have seen an increase in inflammatory diseases in the developed world. [More]
Restricted artificial pancreas use may suffice

Restricted artificial pancreas use may suffice

Restricting use of an artificial pancreas to the evening and nighttime, with standard pump therapy the rest of the time, seems to deliver similar benefits to using one all day and night in patients with Type 1 diabetes, a study suggests. [More]
Researchers produce insulin-secreting cells from stem cells of diabetic patients

Researchers produce insulin-secreting cells from stem cells of diabetic patients

Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St. Louis and Harvard University have produced insulin-secreting cells from stem cells derived from patients with type 1 diabetes. [More]
Digital health: putting patients at the center. An interview with Roz Davies

Digital health: putting patients at the center. An interview with Roz Davies

In England alone the NHS sees 1 million patients every 36 hours and there are 3 million volunteers across health and social care many of whom are motivated by their personal experience of healthcare services. [More]
Mixed picture for diabetes mortality trends

Mixed picture for diabetes mortality trends

A large registry analysis shows that younger people may be missing out on a general decline in mortality rates among patients with diabetes. [More]
Researchers link global increase in type 1 diabetes to advances in medical care

Researchers link global increase in type 1 diabetes to advances in medical care

Researchers from the University of Adelaide say the global increase in cases of type 1 diabetes is directly linked to advances in medical care, with the underlying genetics of the disease more likely to be passed from one generation to the next. [More]
Early viral respiratory infections may increase type 1 diabetes risk in children

Early viral respiratory infections may increase type 1 diabetes risk in children

Viral respiratory infections during the first six months of life are associated with an increased risk for type 1 diabetes. This is the conclusion reached by a team of scientists at the Helmholtz Zentrum München during a study published in the current issue of the renowned US magazine 'JAMA'. [More]
Transplanted human islets provide excellent glycemic control for Type 1 diabetes patients with severe hypoglycemia

Transplanted human islets provide excellent glycemic control for Type 1 diabetes patients with severe hypoglycemia

Northwestern Medicine researchers are co-investigators in a breakthrough clinical trial that found transplanted human islets prevent hypoglycemic events and provide excellent glycemic control for patients with Type 1 diabetes with severe hypoglycemia. The results of the multi-center, single arm, phase III study are published in Diabetes Care on Monday, April 18. The research was funded by National Institute of Health grants through the National Institute of Allergy and Infectious Diseases and the National Institute for Diabetes and Digestive and Kidney Disease. [More]
Advertisement